| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 1655-1665, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Ocqueteau, A Orfao, J Almeida, J Blade, M Gonzalez, R Garcia-Sanz, C Lopez- Berges, MJ Moro, J Hernandez, L Escribano, D Caballero, M Rozman and JF San Miguel
Servicio de Hematologia, Hospital Universitario de Salamanca, Spain.
Although the immunophenotype of plasma cells (PCs) from multiple myeloma (MM) patients has been extensively explored, information on the phenotypic characteristics of PCs in monoclonal gammopathy of undetermined significance (MGUS) patients is scanty and frequently controversial. Thus, the question of whether or not PCs are phenotypically different in the two disorders and whether this criteria could be useful for the differential diagnosis between MGUS and MM remains to be explored. In the present study, the immunophenotypic profile of bone marrow PCs (BMPCs) from a group of 76 MGUS patients has been analyzed by flow cytometry and compared with that of BMPCs present in both MM patients (n = 65) and control subjects (n = 10). For that purpose, a large panel of monoclonal antibodies against PC-related antigens was used together with a sensitive methodology in which a minimum of 10(3) PCs were studied. In all MGUS cases studied, two clearly defined and distinct PC subpopulations could be identified. One PC subpopulation, population A (33 +/- 31% of total PCs), constantly displayed a high CD38 expression with low forward light scatter (FSC)/side light scatter (SSC) and was positive for CD19 and negative for CD56 (only a small proportion of these PCs were weakly positive for CD56). The other PC subpopulation, population B (67 +/- 31% of total PCs), showed the opposite pattern; the antigen CD56 was strongly positive and CD19 was constantly negative, and it showed a lower CD38 expression and higher FSC/SSC values than population A. Clonality studies (cytoplasmic light chain restriction, DNA content studies, and polymerase chain reaction assessment) confirmed the clonal nature of PCs from population B and the polyclonal origin of PCs from population A. Moreover, the polyclonal PCs from MGUS displayed a phenotypic profile identical to that found in PCs from healthy individuals. By contrast, clonal PCs from all MGUS patients displayed a similar antigenic profile to myelomatous PCs, with clear phenotypic differences with respect to normal PCs: lower intensity of CD38 expression and a variable reactivity for markers that were not expressed in normal PCs, such as CD28, CD117, and sIg. Although the presence of residual polyclonal PCs was a constant finding in MGUS patients, it was a rare event in MM and, when present (only 22% of MM cases), its frequency was significantly lower than that observed in MGUS (0.25% versus 32.9%, respectively; P < 0.0001). Only 1.5% of patients with MM had more than 3% of normal PCs, whereas 98% of patients with MGUS had more than 3%. Moreover, as shown by multivariate analysis, the number of residual polyclonal PCs was the most powerful single parameter for the discrimination between MGUS and MM patients at diagnosis, even when only stage I MM cases were considered.
This article has been cited by other articles:
 |
|
 |
|
  G. Mateo, M. A. Montalban, M.-B. Vidriales, J. J. Lahuerta, M. V. Mateos, N. Gutierrez, L. Rosinol, L. Montejano, J. Blade, R. Martinez, et al. Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy J. Clin. Oncol., June 1, 2008; 26(16): 2737 - 2744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Rawstron, A. Orfao, M. Beksac, L. Bezdickova, R. A. Brooimans, H. Bumbea, K. Dalva, G. Fuhler, J. Gratama, D. Hose, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders Haematologica, March 1, 2008; 93(3): 431 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Martin-Ayuso, J. Almeida, M. Perez-Andres, R. Cuello, J. Galende, M. I. Gonzalez-Fraile, G. Martin-Nunez, F. Ortega, M. J. Rodriguez, J. F. San Miguel, et al. Peripheral Blood Dendritic Cell Subsets from Patients with Monoclonal Gammopathies Show an Abnormal Distribution and Are Functionally Impaired Oncologist, January 1, 2008; 13(1): 82 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Perez-Persona, M.-B. Vidriales, G. Mateo, R. Garcia-Sanz, M.-V. Mateos, A. G. de Coca, J. Galende, G. Martin-Nunez, J. M. Alonso, N. de las Heras, et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells Blood, October 1, 2007; 110(7): 2586 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Blade Monoclonal Gammopathy of Undetermined Significance N. Engl. J. Med., December 28, 2006; 355(26): 2765 - 2770. [Full Text] [PDF]
|
|
|
|
|
|
W. J. Chng, R. F. Schop, T. Price-Troska, I. Ghobrial, N. Kay, D. F. Jelinek, M. A. Gertz, A. Dispenzieri, M. Lacy, R. A. Kyle, et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma Blood, October 15, 2006; 108(8): 2755 - 2763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. A. Rayes, A. C. Rawstron, G. J. Morgan, and F. E. Davies The bone marrow microenvironment influences the differential chemokine receptor expression of normal and neoplastic plasma cells Blood, June 15, 2005; 105(12): 4895 - 4896. [Full Text] [PDF]
|
|
|
|
|
|
N. Robillard, C. Pellat-Deceunynck, and R. Bataille Phenotypic characterization of the human myeloma cell growth fraction Blood, June 15, 2005; 105(12): 4845 - 4848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mateo, M. Castellanos, A. Rasillo, N. C. Gutierrez, Ma. A. Montalban, Ma. L. Martin, J. Ma. Hernandez, Ma. C. Lopez-Berges, L. Montejano, J. Blade, et al. Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma Clin. Cancer Res., May 15, 2005; 11(10): 3661 - 3667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rasmussen, M. Kuehl, M. Lodahl, H. E. Johnsen, and I. M. S. Dahl Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors Blood, January 1, 2005; 105(1): 317 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Robillard, H. Avet-Loiseau, R. Garand, P. Moreau, D. Pineau, M.-J. Rapp, J.-L. Harousseau, and R. Bataille CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma Blood, August 1, 2003; 102(3): 1070 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Rawstron, M. R. Yuille, J. Fuller, M. Cullen, B. Kennedy, S. J. Richards, A. S. Jack, E. Matutes, D. Catovsky, P. Hillmen, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion Blood, September 18, 2002; 100(7): 2289 - 2290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Rawstron, M. J. Green, A. Kuzmicki, B. Kennedy, J. A. L. Fenton, P. A. S. Evans, S. J. M. O'Connor, S. J. Richards, G. J. Morgan, A. S. Jack, et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts Blood, June 28, 2002; 100(2): 635 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. PAGNUCCO, L. VANELLI, and F. GERVASI Multidimensional Flow Cytometry Immunophenotyping of Hematologic Malignancy Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. San Miguel, J. Almeida, G. Mateo, J. Blade, C. Lopez-Berges, D. Caballero, J. Hernandez, M. J. Moro, J. Fernandez-Calvo, J. Diaz-Mediavilla, et al. Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome Blood, March 1, 2002; 99(5): 1853 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Guillerm, E. Gyan, D. Wolowiec, T. Facon, H. Avet-Loiseau, K. Kuliczkowski, F. Bauters, P. Fenaux, and B. Quesnel p16INK4a and p15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance Blood, July 1, 2001; 98(1): 244 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Rawstron, J. A. L. Fenton, J. Ashcroft, A. English, R. A. Jones, S. J. Richards, G. Pratt, R. Owen, F. E. Davies, J. A. Child, et al. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells Blood, December 1, 2000; 96(12): 3880 - 3886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dimopoulos, L. A. Moulopoulos, A. Maniatis, and R. Alexanian Solitary plasmacytoma of bone and asymptomatic multiple myeloma Blood, September 15, 2000; 96(6): 2037 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Orfao, G. Schmitz, B. Brando, A. Ruiz-Arguelles, G. Basso, R. Braylan, G. Rothe, F. Lacombe, F. Lanza, S. Papa, et al. Clinically Useful Information Provided by the Flow Cytometric Immunophenotyping of Hematological Malignancies: Current Status and Future Directions Clin. Chem., October 1, 1999; 45(10): 1708 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Avet-Loiseau, T. Facon, A. Daviet, C. Godon, M.-J. Rapp, J.-L. Harousseau, B. Grosbois, and R. Bataille 14q32 Translocations and Monosomy 13 Observed in Monoclonal Gammopathy of Undetermined Significance Delineate a Multistep Process for the Oncogenesis of Multiple Myeloma Cancer Res., September 1, 1999; 59(18): 4546 - 4550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Garcia-Sanz, A. Orfao, M. Gonzalez, M.D. Tabernero, J. Blade, M.J. Moro, J. Fernandez-Calvo, M.A. Sanz, J.A. Perez-Simon, A. Rasillo, et al. Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics Blood, February 1, 1999; 93(3): 1032 - 1037. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
